Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies and antibody-drug conjugates specific for CD123 and uses thereof

Antibodies and antibody-drug conjugates specific for CD123 and uses thereof

US Patent 11613581 · Granted Mar 28, 2023

Estimated economic value: $1,313,906,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-TCR antibody molecules and uses thereof2025
Antibody molecules that bind to NKP30 and uses thereof2025
Multifunctional molecules that bind to T cell related cancer cells and uses ther2025
Antibodies specific for GUCY2c and uses thereof2025
Calicheamicin derivatives and antibody drug conjugates thereof2024
Heteroaryl sulfone-based conjugation handles, methods for their preparation, and2023
Antibodies specific for GUCY2c and uses thereof2022
Antibodies specific for CD3 and uses thereof2022
Cysteine engineered antibody drug conjugates2022
Cysteine engineered antibody drug conjugates2022
Bifunctional cytotoxic agents containing the CTI pharmacophore2022
Bifunctional cytotoxic agents containing the CTI pharmacophore2020